Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly

PHASE3CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2011

Conditions
GlioblastomaAnaplastic Astrocytoma
Interventions
DRUG

Temozolomide

100 mg/m2 per day on seven out of fourteen days.

RADIATION

Radiotherapy of the partial brain.

60 Gy in 30 fractions à 2 Gy.

Trial Locations (23)

8091

University of Zurich, Zurich

60528

University of Frankfurt, Frankfurt am Main

69120

University of Heidelberg, Heidelberg

Unknown

Charite Berlin, Berlin

University of Bochum, Bochum

University of Bonn, Bonn

University of Dresden, Dresden

University of Düsseldorf, Düsseldorf

University of Erlangen, Erlangen

University of Essen, Essen

University of Freiburg, Freiburg im Breisgau

University of Hamburg, Hamburg

University of Hannover II, Hanover

University of Hannover, Hanover

University of Homburg, Homburg

University of Kiel, Kiel

University of Leipzig, Leipzig

University of Mainz, Mainz

University of Heidelberg, Mannheim

University of Marburg, Marburg

University of Regensburg, Regensburg

University of Tübingen, Tübingen

University of Ulm, Ulm

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT01502241 - Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly | Biotech Hunter | Biotech Hunter